Clinical Impact of Donor-Specific Antibodies on Intestinal Allograft Rejection and Survival.

被引：0
|
作者：
Cheng, Elaine Y. [1 ,4 ]
Wozniak, Laura J. [2 ]
Venick, Robert S. [1 ,2 ]
Marcus, Elizabeth A. [2 ]
Hwang, Vilayphone [3 ]
Crowley, Stacey [3 ]
Everly, Matthew J. [4 ]
Terasaki, Paul I. [4 ]
McDiarmid, Sue V. [2 ]
Farmer, Douglas G. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
[3] Ronald Reagan UCLA Med Ctr, Dept Transplant Adm, Los Angeles, CA USA
[4] Terasaki Fdn Labs, Los Angeles, CA USA
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
368
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [31] Donor-Specific Antibodies Correlate with Rejection in Heart Transplant Patients
    Patel, N.
    Pavlovic-Surjancev, B.
    Sinacore, J.
    Susskind, B.
    Neuswanger, N.
    Dasari, T.
    Heroux, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S92 - S92
  • [32] Association of the Non-HLA, ATIR Antibody, and Donor Specific HLA Antibodies to Renal Allograft Survival.
    Bihari, L.
    Saltarrelli, J.
    Lappin, J.
    Katz, S.
    Varga, K.
    Van Buren, C.
    Cook, D.
    Heidecke, H.
    Dragun, D.
    Kennan, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 165 - 165
  • [33] Impact of the immunotherapy induction on allograft outcome and survival in kidney transplant patients with donor-specific antibodies to HLA-DQB1
    Dutra, Rodrigo S.
    Fabreti-Oliveira, Raquel A.
    Lasmar, Marcus F.
    Araujo, Stanley A.
    Nascimento, Evaldo
    TRANSPLANT IMMUNOLOGY, 2021, 66
  • [34] The Impact of De Novo Donor-Specific Antibodies on Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome
    Miyamoto, E.
    Martinu, T.
    Klement, W.
    Juvet, S.
    Keshavjee, S.
    Tinckam, K.
    Tikkanen, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S34 - S34
  • [35] The Impact of Rituximab On Renal Allograft Outcomes in Patients With Preformed Low Level Donor-Specific Antibodies
    Ravichandran, B.
    Manitpisitkul, W.
    Gillespie, M.
    Wilson, N.
    Ugarte, R.
    Bartlett, S.
    Haririan, A.
    TRANSPLANTATION, 2014, 98 : 439 - 439
  • [36] Early Donor-Specific Anti-HLA Antibodies in Lung Transplantation: Impact on Survival and Risk of Chronic Lung Allograft Dysfunction
    Le Pavec, J.
    Lamrani, L.
    Suberbielle, C.
    Thabut, G.
    Fabre, D.
    Mussot, S.
    Dartevelle, P.
    Mercier, O.
    Fadel, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S252 - S252
  • [37] The Impact of Rituximab On Renal Allograft Outcomes in Patients With Preformed Low Level Donor-Specific Antibodies
    Ravichandran, B.
    Manitpisitkul, W.
    Gillespie, M.
    Wilson, N.
    Ugarte, R.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 439 - 439
  • [38] Impact of Pretransplant Donor-Specific Antibodies on Kidney Allograft Recipients with Negative Flow Cytometry Crossmatches
    Kwon, Hyunwook
    Kim, Young Hoon
    Choi, Ji Yoon
    Shin, Sung
    Jung, Joo Hee
    Cho, Min Jae
    Kim, Jee Yeon
    Ha, Duck Jong
    TRANSPLANTATION, 2018, 102 : S623 - S624
  • [39] The interplay of donor-specific antibodies, allograft C4d deposition, and antibody-mediated rejection
    Naber, Urs
    Feingold, Brian
    PEDIATRIC TRANSPLANTATION, 2013, 17 (05) : 409 - 411
  • [40] Donor-specific antibodies following liver and intestinal transplantation: Clinical significance, pathogenesis and recommendations
    Wozniak, Laura J.
    Venick, Robert S.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2019, 38 (03) : 106 - 117
12345